News

Best stocks to buy today, 16 July, recommended by NeoTrader's Raja Venkatraman
Tariff war seems to be getting discounted as it was unable to really trigger any further negative bias. This was a positive ...
Higher CPI Inflation In June Encourages Focus On Margins
Explore June's rising CPI inflation, the Fed's likely rate stance, and market opportunities in non-cyclicals and high-margin ...
Breaking Down BioNTech: 12 Analysts Share Their Views
The 12-month price targets, analyzed by analysts, offer insights with an average target of $133.42, a high estimate of $155.00, and a low estimate of $110.00. A negative shift in sentiment is evident ...
Verastem: The Market Is Ignoring The Progress
Verastem's FDA approval for KRAS-mutant LGSOC, strong pipeline, and catalysts signal growth potential. Click here to read an ...
WHO Extended Global Emergency Status of MPox Epidemic - Development of Treatment for MPox with NV-387 is Timely, Says NanoViricides - The Tennessean
SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the ...
Ensysce Biosciences Initiates Pivotal Phase 3 Study of PF614 - A Next-Generation Opioid - Designed to Deliver Powerful Pain Relief and Reduce Abuse
FDA Protocol Review Completed ~ ~ Rho, Inc. Selected as Clinical Research Partner ~ SAN DIEGO, CA / ACCESS Newswire / July 16, 2025 /Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company" ...